What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
His main research concerns Psychiatry, Major depressive disorder, Depression, Randomized controlled trial and Internal medicine.
Madhukar H. Trivedi works mostly in the field of Psychiatry, limiting it down to concerns involving Clinical psychology and, occasionally, Prefrontal cortex.
The study incorporates disciplines such as Antidepressant, Citalopram, STAR*D and Sertraline in addition to Major depressive disorder.
Madhukar H. Trivedi interconnects Physical therapy, Mood, Prospective cohort study, Severity of illness and Pediatrics in the investigation of issues within Depression.
The Randomized controlled trial study combines topics in areas such as Placebo, Clinical trial, Bupropion and Mirtazapine.
His work on Randomization as part of general Internal medicine research is frequently linked to Context, bridging the gap between disciplines.
His most cited work include:
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2853 citations)
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice (2525 citations)
- The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. (2157 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Depression, Major depressive disorder, Psychiatry, Internal medicine and Antidepressant.
Particularly relevant to STAR*D is his body of work in Depression.
His Major depressive disorder course of study focuses on Randomized controlled trial and Intervention.
His study looks at the relationship between Psychiatry and fields such as Clinical trial, as well as how they intersect with chemical problems.
Mirtazapine is closely connected to Escitalopram in his research, which is encompassed under the umbrella topic of Internal medicine.
His work on Psychometrics and Mood as part of general Clinical psychology research is often related to Suicidal ideation, thus linking different fields of science.
He most often published in these fields:
- Depression (46.91%)
- Major depressive disorder (47.16%)
- Psychiatry (45.15%)
What were the highlights of his more recent work (between 2018-2021)?
- Major depressive disorder (47.16%)
- Depression (46.91%)
- Internal medicine (28.75%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Major depressive disorder, Depression, Internal medicine, Antidepressant and Placebo.
His Hamilton Rating Scale for Depression study in the realm of Major depressive disorder connects with subjects such as Pimavanserin.
His Depression study is associated with Psychiatry.
Madhukar H. Trivedi combines subjects such as Treatment-resistant depression, Oncology and Cardiology with his study of Internal medicine.
His Antidepressant research incorporates elements of Gastroenterology, Treatment outcome, C-reactive protein and Treatment response.
His work carried out in the field of Placebo brings together such families of science as Physical medicine and rehabilitation, Rating scale, Clinical endpoint, Sertraline and Serotonin reuptake inhibitor.
Between 2018 and 2021, his most popular works were:
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (131 citations)
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. (111 citations)
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (97 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary areas of study are Major depressive disorder, Depression, Internal medicine, Antidepressant and Placebo.
His research on Major depressive disorder focuses in particular on Hamilton Rating Scale for Depression.
Research on Psychiatry and Neuroscience is a part of his Depression study.
As a part of the same scientific family, Madhukar H. Trivedi mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Proinflammatory cytokine, Cytokine, Pathophysiology and Inflammation.
His studies in Antidepressant integrate themes in fields like Gastroenterology, Treatment outcome, Clinical psychology and C-reactive protein.
His Placebo research incorporates themes from Serotonin reuptake inhibitor, Physical therapy, Treatment-resistant depression and Sertraline.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
